AiCure

Emerging Markets

KCI expands operations in Brazil

Friday, September 14, 2012 11:44 AM

KCI, a global medical technology company, is expanding existing operations in Brazil.

More... »


Pfizer, Hisun launch joint venture Hisun-Pfizer Pharmaceuticals

Friday, September 14, 2012 11:13 AM

Pfizer, the world's largest research-based pharmaceutical company, and Zhejiang Hisun Pharmaceuticals, a Chinese pharmaceutical company, have launched their joint venture Hisun-Pfizer Pharmaceuticals, to develop, manufacture and commercialize off-patent pharmaceutical products in China and global markets.

More... »


Abbott, Syngene to open first nutrition R&D center in India

Friday, May 4, 2012 08:01 AM

Abbott, one of India's largest health care companies, is collaborating with Syngene, an Indian CRO and subsidiary of Biocon, to establish its first nutrition R&D center in the country.

More... »

OrbiMed launches $222 million fund in Israel life sciences

Tuesday, April 24, 2012 12:18 PM

OrbiMed, a global investment management firm focused on the healthcare sector, has closed its first investment fund dedicated to life sciences venture capital opportunities based in Israel. The Fund, OrbiMed Israel Partners Limited Partnership, includes an anchor investment provided by the government of Israel, which also provided special economic terms through the initial tender process for the Fund.

More... »

Marken continues expansion with Buenos Aires facility

Tuesday, December 20, 2011 01:39 PM

Marken continues their expansion of services in Latin America, by augmenting their new purpose-built Buenos Aires facility.

More... »

Russia's cancer drug market to grow to $163 million

Wednesday, December 14, 2011 12:48 PM

Decision Resources, a research and advisory firm for pharmaceutical and healthcare issues, has found that the Russian market for non-small-cell lung cancer therapies will grow 3% annually from 2010 to 2015 to $163 million in 2015. According to the Emerging Markets report, Non-Small-Cell Lung Cancer in Russia, an increase in the incident population, gradually increasing use of higher-priced chemotherapies and the introduction of several premium-priced agents will promote this growth.

More... »

Middle East region poised for clinical trials growth

Monday, October 24, 2011 08:00 AM

With sponsors and CROs still on the hunt for emerging markets rife with treatment-naive patients and good infrastructure, interest in the Middle East is increasing.

More... »

DIA names director of DIA India

Monday, October 17, 2011 12:00 PM

DIA has named Kaushik Desai as director of DIA India. Kaushik brings to DIA both a deep knowledge of the global regulatory framework and the pharmaceutical environment in India as well as a passion for the vision and mission of the association.

More... »

Actavis expands to Latin America

Friday, October 7, 2011 11:49 AM

Actavis Group CEO Claudio Albrecht has reported a major sales expansion into Latin America, among the world's fastest-growing markets for generic drugs.

More... »

Sponsors must consider the challenges as well as advantages when moving trials to emerging markets

Monday, January 10, 2011 07:00 AM

As drug sponsors increasingly look to emerging markets for greater patient access and lower trial costs, they must also consider the potential disadvantages of moving operations to a developing country when choosing the best location for a clinical trial, according to new research from Cutting Edge Information.

More... »

`
CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

November 24

Tufts CSDD’s $2.6 billion price tag to develop and bring a new drug to market raises questions, criticisms

Medidata joins GlaxoSmithKline in study to evaluate the impact of wearing mobile devices in clinical trials

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

November

Private equity driving dynamic CRO growth
Enables CROs to pursue long-term strategies, while giving the space credibility

Baby boomers poised to reshape clinical trials industry
Millions of tech-savvy consumers already track their health, expect new treatments as they age

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

October

CROs driving changes in patient recruitment
Data- and tech-aided enrollment services a competitive advantage

Trials with in-home nurses poised to grow
Higher expense, but may improve recruitment and retention for select trials

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs